Morgan Stanley Backs Tenaya Therapeutics (TNYA) as SMID-Cap Biotech Primed to Outperform in 2026
Tenaya Therapeutics Inc. (NASDAQ:TNYA) is one of the overlooked growth stocks to buy.
Tenaya Therapeutics Inc. (TNYA)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Millennium Management Israel Englander | 4,615,746 | $3,284,103 | +3% | 0% |
| 2. | Citadel Investment Group Ken Griffin | 4,200,000 | $2,988,300 | 0% | |
| 3. | Anson Investments Amin Nathoo And Moez Kassam | 4,152,966 | $2,954,835 | 0.28% | |
| 4. | Alyeska Investment Group Anand Parekh | 4,000,000 | $2,846,000 | 0.01% | |
| 5. | Burkehill Global Management Christopher Rich | 2,000,000 | $1,423,000 | 0.09% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.70 | 35,714,284 | $24,999,998.80 | 49,313,559 | 2025-03-05 | Filing | |
| $0.70 | 35,714,284 | $24,999,998.80 | 49,313,559 | 2025-03-05 | Filing | |
| $4.50 | 2,222,222 | $9,999,999.00 | 13,599,275 | 2024-02-12 | Filing | |
| $4.50 | 2,222,222 | $9,999,999.00 | 13,599,275 | 2024-02-12 | Filing | |
| $2.60 | 6,779 | $17,595.57 | 11,377,053 | 2023-03-10 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.64 | 2,022 | $1,300.35 | 119,752 | 2026-02-17 | Filing | |
| $0.64 | 836 | $537.88 | 121,774 | 2026-02-17 | Filing | |
| $0.64 | 611 | $393.12 | 122,610 | 2026-02-17 | Filing | |
| $0.64 | 5,032 | $3,235.58 | 443,404 | 2026-02-17 | Filing | |
| $0.64 | 3,979 | $2,558.89 | 448,436 | 2026-02-17 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 9,400,290 | $6,693,006 | 8.08% | |
| 2. | 8,560,108 | $6,094,797 | 0% | |
| 3. | 5,414,101 | $3,852,133 | 3.4% | |
| 4. | 3,948,586 | $2,809,419 | 0% | |
| 5. | 1,266,075 | $900,812 | 0% |
News See All
9 Overlooked Growth Stocks to Buy
On January 12, Victoria Greene, Founding Partner and CIO at G Squared Private Wealth, joined CNBC to discuss her current market outlook, selecting 'Fundamentals' as her word of the day.
Morgan Stanley Reduces PT on Tenaya Therapeutics (TNYA), Keeps Constructive Stance on U.S. Small- to Mid-Cap Biotech
On January 8, 2026, TheFly reported that Morgan Stanley reduced its price target on Tenaya Therapeutics, Inc. (NASDAQ:TNYA) from $5 to $2, while reiterating an ‘Overweight’ rating.
10 Stocks Under $1 That Will Explode
U.S. equity markets are beginning their 2026 journey without taking a major break from existing trends, according to Morgan Stanley CIO and chief U.S.
13 Penny Stocks with Insider Buying in 2024
In this article, we will take a detailed look at the 13 Penny Stocks with Insider Buying in 2024. If you want to skip our detailed analysis and see the top 5 stocks in this list, click 5 Penny Stocks...
14 Stocks With Heavy Insider Buying In 2024
Markets await latest inflation numbers and the debate regarding soft vs hard landing is expected to persist in the Wall Street for months to come.
5 Little-Known Penny Stocks With Massive Upside Potential
This article presents an overview of the 5 Little-Known Penny Stocks With Massive Upside Potential. For a detailed overview of such stocks, read our article, 11 Little-Known Penny Stocks With Massive...
10 Best Biotech Stocks Under $10
In this article, we will look at the 10 best biotech stocks under $10.
Harvard University's Latest Portfolio: 10 Best Biotech Stock Picks
In this article, we will look at Harvard University's latest stock portfolio and list its 10 best biotech stock picks.
5 Best Biotech and AI Stocks To Buy According To Billionaire Jim Simons
In this article, we discuss 5 stock picks of Jim Simons’ Euclidean Capital.
Hedge Fund Resource Center